Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureZehao Cai, Kuan He, Lingfeng Tang, Haozheng Tang, Jihan Qiu, Hanzhi Li, Shipeng Guo, Meiying Shen, Shun Gao, Shengchun Liu
Abstract
Authors
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Breast cancer statistics 2024
2024
Cancer treatment and survivorship statistics, 2025
2025
Extending the duration of endocrine treatment for early breast cancer: patient-level meta-analysis of 12 randomised trials of aromatase inhibitors in 22,031 postmenopausal women already treated with at least 5 years of endocrine therapy
10.1016/s0140-6736(25)01013-x · 2025
Metabolomic rewiring promotes endocrine therapy resistance in breast cancer
10.1158/0008-5472.can-23-0184 · 2024
Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways
10.1073/pnas.1816391116 · 2019
Mechanisms of genome instability from cellular folate stress
10.1083/jcb.202502205 · 2025
Toward a better understanding of folate metabolism in health and disease
10.1084/jem.20181965 · 2019
Folic acid modulates VPO1 DNA methylation levels and alleviates oxidative stress-induced apoptosis in vivo and in vitro
10.1016/j.redox.2018.08.005 · 2018
Beyond the Warburg effect: how do cancer cells regulate one-carbon metabolism?
10.3389/fcell.2018.00090 · 2018
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
unpaywall
Confidence 95%
datacite
Confidence 0%
The role of nutrients in protecting mitochondrial function and neurotransmitter signaling: implications for the treatment of depression, PTSD, and suicidal behaviors
10.1080/10408398.2013.876960 · 2016
Serine and one-carbon metabolism in cancer
10.1038/nrc.2016.81 · 2016
Inactivation of folylpolyglutamate synthetase Met7 results in genome instability driven by an increased dUTP/dTTP ratio
2020
Functionalizing of magnetic nanoparticles as nano-architecture towards bioimaging and colorimetric recognition of MCF-7 cells: dual opto-sensing and fluorescence monitoring for early-stage diagnosis of breast cancer
10.1007/s00604-024-06826-y · 2024
A phase II trial to evaluate the safety and immunogenicity of two doses of a folate receptor alpha vaccine in patients with triple negative breast cancer
2025
Antibody drug conjugate targets are highly differentially expressed across the major types of ovarian cancer
10.1016/j.ejca.2025.115522 · 2025
Folate intake, tissue levels, and colorectal cancer deaths in a national cohort established before folic acid fortification
10.1007/s00394-025-03720-y · 2025
Association of folate intake and plasma folate level with the risk of breast cancer: a dose-response meta-analysis of observational studies
10.18632/aging.103881 · 2020
Folate and breast cancer: the role of polymorphisms in methylenetetrahydrofolate reductase (MTHFR)
10.1016/s0304-3835(02)00030-7 · 2002
Regulation of folate and one-carbon metabolism in mammalian cells. I. Folate metabolism in Chinese hamster ovary cells expressing Escherichia coli or human folylpoly-gamma-glutamate synthetase activity
10.1016/s0021-9258(20)80592-4 · 1993
Effects of overexpression of gamma-Glutamyl hydrolase on methotrexate metabolism and resistance
2001
Identification and characterization of genetic variation in the folylpolyglutamate synthase gene
10.1158/0008-5472.can-07-0156 · 2007
Folylpolyglutamate synthetase inactivation in relapsed ALL induces a druggable folate metabolic vulnerability
10.1016/j.drup.2024.101141 · 2024
Effects of folylpolyglutamate synthetase modulation on chemosensitivity of colon cancer cells to 5-fluorouracil and methotrexate
10.1136/gut.2004.042713 · 2004
Associations between TS, TTF-1, FR-α, FPGS, and overall survival in patients with advanced non-small-cell lung cancer receiving pemetrexed plus carboplatin or gemcitabine plus carboplatin as first-line chemotherapy
10.1097/jto.0b013e3182a406a3 · 2013
Folylpoly-glutamate synthetase expression is associated with tumor response and outcome from pemetrexed-based chemotherapy in malignant pleural mesothelioma
10.1097/jto.0b013e318260deaa · 2012
Effects of folylpolyglutamate synthase modulation on global and gene-specific DNA methylation and gene expression in human colon and breast cancer cells
10.1016/j.jnutbio.2015.10.019 · 2016
The role of B12 deficiency and methionine synthase in methionine-dependent cancer cells
10.1186/s40170-025-00405-2 · 2025
Folic acid depletion as well as oversupplementation helps in the progression of hepatocarcinogenesis in HepG2 cells
10.1038/s41598-022-21084-9 · 2022
Organelle-specific autophagy in inflammatory diseases: a potential therapeutic target underlying the quality control of multiple organelles
10.1080/15548627.2020.1725377 · 2021
Mitophagy's impacts on cancer and neurodegenerative diseases: implications for future therapies
10.1186/s13045-025-01727-w · 2025
Cyclin-dependent kinases
10.1186/gb4184 · 2014
A precision medicine drug discovery pipeline identifies combined CDK2 and 9 inhibition as a novel therapeutic strategy in colorectal cancer
10.1158/1535-7163.mct-20-0454 · 2020
One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer
10.1158/0008-5472.can-04-2630 · 2005
Association of folate metabolism-related enzymes (MTHFR, MYD88, and TP53) and their single nucleotide polymorphisms with breast cancer susceptibility in women from Southwest China: a Bayesian network approach
2025
Balancing the scales: folic acid and vitamin B12 in the aggressiveness of hepatocellular carcinoma
10.1007/s10238-025-01799-5 · 2025
Compartmentalization of mammalian folate-mediated one-carbon metabolism
10.1146/annurev.nutr.012809.104810 · 2010
Serine, glycine and one-carbon units: cancer metabolism in full circle
10.1038/nrc3557 · 2013
A dual-targeting peptide-drug conjugate based on CXCR4 and FOLR1 inhibits triple-negative breast cancer
10.1016/j.apsb.2025.06.012 · 2025
Dual-targeted Pt@Ce-MOF nanoplatform enhances radiotherapy efficacy via tumor-specific delivery and mitochondrial dysfunction in breast cancer
10.1002/bip.70054 · 2025
Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer
10.1038/ncomms4128 · 2014
Discovery of a potent, selective and orally bioavailable CDK9 degrader for targeting transcription regulation in triple-negative breast cancer
10.1016/j.bioorg.2024.107876 · doi-reference
CDK9 targeting PROTAC L055 inhibits ERα-positive breast cancer
10.1016/j.biopha.2024.116972 · doi-reference
Clinical considerations for the design of PROTACs in cancer
10.1186/s12943-022-01535-7 · doi-reference
CDK9 inhibition blocks the initiation of PINK1-PRKN-mediated mitophagy by regulating the SIRT1-FOXO3-BNIP3 axis and enhances the therapeutic effects involving mitochondrial dysfunction in hepatocellular carcinoma
10.1080/15548627.2021.2007027 · doi-reference
CircFUNDC1 interacts with CDK9 to promote mitophagy in nucleus pulposus cells under oxidative stress and ameliorates intervertebral disc degeneration
10.1038/s41419-025-07425-2 · doi-reference
CREPT promotes LUAD progression by enhancing the CDK9 and RNAPII assembly to promote ERK-driven gene transcription
10.7150/thno.115572 · doi-reference
Targeting processive transcription for Myc-driven circuitry in medulloblastoma
10.1093/neuonc/noaf121 · doi-reference
CDK9: therapeutic perspective in HCC therapy
10.2174/1568009620666200212124357 · doi-reference
CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphoma
10.1186/s12943-023-01762-6 · doi-reference
Novel agents and regimens in relapsed or refractory peripheral T-cell lymphoma: latest updates from 2023 ASH annual meeting
10.1186/s40164-024-00510-w · doi-reference
CDK9 keeps RNA polymerase II on track
10.1007/s00018-021-03878-8 · doi-reference
P-TEFb: the master regulator of transcription elongation
10.1016/j.molcel.2022.12.006 · doi-reference
Histone deacetylase inhibitors induce FPGS mRNA expression and intracellular accumulation of long-chain methotrexate polyglutamates in childhood acute lymphoblastic leukemia: implications for combination therapy
10.1038/leu.2009.282 · doi-reference
Increasing dosage of leucovorin results in pharmacokinetic and gene expression differences when administered as two-hour infusion or bolus injection to patients with colon cancer
10.3390/cancers15010258 · doi-reference
Role of mitochondrial and cytosolic folylpolyglutamate synthetase in one-carbon metabolism and antitumor efficacy of mitochondrial-targeted antifolates
10.1124/molpharm.124.000912 · doi-reference
Molecular basis of antifolate resistance
10.1007/s10555-007-9049-z · doi-reference
Comparative oncogenomics identifies PSMB4 and SHMT2 as potential cancer driver genes
10.1158/0008-5472.can-13-2683 · doi-reference